Lubrizol LifeSciences to Highlight Complex Product Development Capabilities of Particle Sciences at 2016 AAPS Conference
(Thomson Reuters ONE) -
The Lubrizol Corporation
29400 Lakeland Blvd, Wickliffe, OH 44092
Lubrizol LifeSciences to Highlight Complex Product Development Capabilities
of Particle Sciences at 2016 AAPS Conference
CLEVELAND, November 14, 2016 -The Lubrizol Corporation's LifeSciences business,
a leading supplier of services and advanced materials for the pharmaceutical and
medical device industry, announces it will showcase its expanded range of
solutions for the pharmaceutical industry at the 2016 American Association of
Pharmaceutical Scientists (AAPS) annual meeting and exposition November 14 -17
at the Colorado Convention Center in Denver, Colorado (Booth #1127).
Lubrizol LifeSciences will highlight the drug product development capabilities
of Particle Sciences - a leading contract drug development and manufacturing
organization with a comprehensive suite of services for the formulation,
analysis and production of complex drug delivery solutions.
Lubrizol LifeSciences continues to expand its capabilities at Particle Sciences,
providing full service cGMP drug product development and manufacturing across a
variety of sterile and non-sterile complex dosage forms such as micro/nano-
particulates, emulsions and drug-eluting devices. "With the new investment in
over 2,700 ft(2) of commercial cleanroom space, we continue to demonstrate our
commitment to be the leading CDMO for complex drug products. Our organization
has a depth of knowledge and resources found nowhere else," stated Mark
Mitchnick M.D., CEO, Particle Sciences Inc., chief medical officer, Lubrizol
LifeSciences.
Lubrizol LifeSciences' newest product, Transform(TM), is the only hydrate-able
topical film that offers wide API compatibility, value and convenience all in
one. Transform films make loading APIs for drug delivery fast and easy. This can
eliminate additional raw materials and processing steps of lamination and
multiple components. Improved patient comfort is another benefit as Transform is
a cool, comfortable, transparent film designed for optimal aesthetics and
therapeutic benefit.
- more -
About Lubrizol LifeSciences
Lubrizol LifeSciences is a healthcare solution partner that provides customer
support from idea to execution by supplying customizable polymers and
excipients, complex drug formulation development and best-in-class contract
manufacturing services for medical device and pharmaceutical manufacturers. The
combination of our polymer expertise, drug formulation development and quality
contract manufacturing allows LifeSciences to offer our customers end-to-end
solutions for success in the drug delivery market.
About Particle Sciences
Particle Sciences, now part of Lubrizol LifeSciences, is an integrated provider
of drug development and manufacturing services. Particle Sciences focuses on BCS
II/III/IV molecules, biologics and highly potent compounds through a variety of
technologies including emulsions, gels, micro and nano-particulates, drug/device
combination products, solid solutions and others. Through a full range of
formulation, analytic and manufacturing services, Particle Sciences provides
pharmaceutical companies with a complete and seamless development and
manufacturing solution that minimizes the time and risk between discovery and
commercialization. The company was founded in 1991 and is headquartered in
Bethlehem, Pennsylvania. Visit www.particlesciences.com, email
info(at)particlesciences.com, or contact us at (610) 861- 4701 for information.
About The Lubrizol Corporation
The Lubrizol Corporation, a Berkshire Hathaway company, is a technology-driven
global company that combines complex, specialty chemicals to optimize the
quality, performance and value of customers' products while reducing their
environmental impact. It produces and supplies technologies to customers in the
global transportation, industrial and consumer markets. These technologies
include lubricant additives for engine oils, driveline and other transportation-
related fluids, industrial lubricants, as well as additives for gasoline and
diesel fuel. In addition, Lubrizol makes ingredients and additives for home care
and personal care products and specialty materials encompassing polymer and
coatings technologies, along with polymer-based pharmaceutical and medical
device solutions. Our products for the oilfield market include technologies for
exploration, production and transportation.
With headquarters in Wickliffe, Ohio, Lubrizol owns and operates manufacturing
facilities in 17 countries, as well as sales and technical offices around the
world. Founded in 1928, Lubrizol has approximately 9,000 employees worldwide.
Revenues for 2015 were $7 billion. For more information, visit Lubrizol.com.
Particle Sciences is part of Lubrizol Advanced Materials, Inc.
Transform(TM) is a trademark of The Lubrizol Corporation.
Media Contact
Ben Patti
(216) 447-5827
www.lubrizol.com/LifeSciences
###
This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Lubrizol via GlobeNewswire
Unternehmensinformation / Kurzprofil:
Datum: 14.11.2016 - 17:00 Uhr
Sprache: Deutsch
News-ID 506832
Anzahl Zeichen: 5989
contact information:
Town:
Wickliffe, Ohio
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 190 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Lubrizol LifeSciences to Highlight Complex Product Development Capabilities of Particle Sciences at 2016 AAPS Conference"
steht unter der journalistisch-redaktionellen Verantwortung von
Lubrizol (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
